Literature DB >> 20494602

A mutation in canine PPT1 causes early onset neuronal ceroid lipofuscinosis in a Dachshund.

Douglas N Sanders1, Fabiana H Farias, Gary S Johnson, Vivian Chiang, James R Cook, Dennis P O'Brien, Sandra L Hofmann, Jui-Yun Lu, Martin L Katz.   

Abstract

The neuronal ceroid lipofuscinoses (NCLs) are lysosomal storage diseases characterized by progressive neurodegeneration and accumulation of autofluorescent storage granules. A 9-month-old Miniature Dachshund presented with NCL-like signs that included disorientation, ataxia, weakness, visual impairment, and behavioral changes. Neurons throughout the CNS contained autofluorescent lysosomal inclusions with granular osmiophilic deposit (GROD) ultrastructure characteristic of classical infantile NCL (INCL). Human INCL is an autosomal recessive disorder that results from mutations in PPT1, a gene that encodes the enzyme palmitoyl protein thioesterase 1 (PPT1; EC 3.1.22). Resequencing of PPT1 from the affected dog revealed that the dog was homozygous for a single nucleotide insertion in exon 8 (PPT1 c.736_737insC), upstream from the His289 active site. Brain tissue from this dog lacked PPT1 activity. The sire and dam of the propositus were heterozygous for the c.736_737insC mutation; whereas, 127 unrelated Dachshunds were homozygous for the wild-type allele. This is the first reported instance of canine NCL caused by a mutation in PPT1. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20494602      PMCID: PMC2930207          DOI: 10.1016/j.ymgme.2010.04.009

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  45 in total

Review 1.  Thematic review series: lipid posttranslational modifications. Lysosomal metabolism of lipid-modified proteins.

Authors:  Jui-Yun Lu; Sandra L Hofmann
Journal:  J Lipid Res       Date:  2006-04-20       Impact factor: 5.922

2.  Neuronal ceroid lipofuscinosis in Devon cattle is caused by a single base duplication (c.662dupG) in the bovine CLN5 gene.

Authors:  Peter J Houweling; Julie A L Cavanagh; David N Palmer; Tony Frugier; Nadia L Mitchell; Peter A Windsor; Herman W Raadsma; Imke Tammen
Journal:  Biochim Biophys Acta       Date:  2006-07-25

3.  A missense mutation (c.184C>T) in ovine CLN6 causes neuronal ceroid lipofuscinosis in Merino sheep whereas affected South Hampshire sheep have reduced levels of CLN6 mRNA.

Authors:  Imke Tammen; Peter J Houweling; Tony Frugier; Nadia L Mitchell; Graham W Kay; Julie A L Cavanagh; Roger W Cook; Herman W Raadsma; David N Palmer
Journal:  Biochim Biophys Acta       Date:  2006-09-12

4.  Ocular phenotype in a mouse gene knockout model for infantile neuronal ceroid lipofuscinosis.

Authors:  Bo Lei; Gregory E Tullis; Mark D Kirk; Keqing Zhang; Martin L Katz
Journal:  J Neurosci Res       Date:  2006-10       Impact factor: 4.164

5.  The gene mutated in variant late-infantile neuronal ceroid lipofuscinosis (CLN6) and in nclf mutant mice encodes a novel predicted transmembrane protein.

Authors:  Ruth B Wheeler; Julie D Sharp; Roger A Schultz; John M Joslin; Ruth E Williams; Sara E Mole
Journal:  Am J Hum Genet       Date:  2001-11-27       Impact factor: 11.025

6.  A new large animal model of CLN5 neuronal ceroid lipofuscinosis in Borderdale sheep is caused by a nucleotide substitution at a consensus splice site (c.571+1G>A) leading to excision of exon 3.

Authors:  Tony Frugier; Nadia L Mitchell; Imke Tammen; Peter J Houweling; Donald G Arthur; Graham W Kay; Otto P van Diggelen; Robert D Jolly; David N Palmer
Journal:  Neurobiol Dis       Date:  2007-09-29       Impact factor: 5.996

7.  An adult case of canine neuronal ceroid-lipofuscinosis.

Authors:  J F Cummings; A de Lahunta
Journal:  Acta Neuropathol       Date:  1977-07-15       Impact factor: 17.088

8.  The novel neuronal ceroid lipofuscinosis gene MFSD8 encodes a putative lysosomal transporter.

Authors:  Eija Siintola; Meral Topcu; Nina Aula; Hannes Lohi; Berge A Minassian; Andrew D Paterson; Xiao-Qing Liu; Callum Wilson; Ulla Lahtinen; Anna-Kaisa Anttonen; Anna-Elina Lehesjoki
Journal:  Am J Hum Genet       Date:  2007-05-14       Impact factor: 11.025

Review 9.  Mannose 6-phosphate receptor targeting and its applications in human diseases.

Authors:  M Gary-Bobo; P Nirdé; A Jeanjean; A Morère; M Garcia
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

10.  A frame shift mutation in canine TPP1 (the ortholog of human CLN2) in a juvenile Dachshund with neuronal ceroid lipofuscinosis.

Authors:  Tomoyuki Awano; Martin L Katz; Dennis P O'Brien; Istvan Sohar; Peter Lobel; Joan R Coates; Shahnawaz Khan; Gayle C Johnson; Urs Giger; Gary S Johnson
Journal:  Mol Genet Metab       Date:  2006-04-18       Impact factor: 4.204

View more
  29 in total

Review 1.  Large animal models for Batten disease: a review.

Authors:  Krystal Weber; David A Pearce
Journal:  J Child Neurol       Date:  2013-09       Impact factor: 1.987

Review 2.  Canine epilepsy genetics.

Authors:  Kari J Ekenstedt; Edward E Patterson; James R Mickelson
Journal:  Mamm Genome       Date:  2011-10-30       Impact factor: 2.957

3.  Intravenous high-dose enzyme replacement therapy with recombinant palmitoyl-protein thioesterase reduces visceral lysosomal storage and modestly prolongs survival in a preclinical mouse model of infantile neuronal ceroid lipofuscinosis.

Authors:  Jie Hu; Jui-Yun Lu; Andrew M S Wong; Linda S Hynan; Shari G Birnbaum; Denis S Yilmaz; Barbara M Streit; Ewelina M Lenartowicz; Thomas C M Thompson; Jonathan D Cooper; Sandra L Hofmann
Journal:  Mol Genet Metab       Date:  2012-05-22       Impact factor: 4.797

4.  Multifocal retinopathy in Dachshunds with CLN2 neuronal ceroid lipofuscinosis.

Authors:  Rebecca E H Whiting; Jacqueline W Pearce; Leilani J Castaner; Cheryl A Jensen; Rebecca J Katz; Douglas H Gilliam; Martin L Katz
Journal:  Exp Eye Res       Date:  2015-02-16       Impact factor: 3.467

Review 5.  Canine neuronal ceroid lipofuscinoses: Promising models for preclinical testing of therapeutic interventions.

Authors:  Martin L Katz; Eline Rustad; Grace O Robinson; Rebecca E H Whiting; Jeffrey T Student; Joan R Coates; Kristina Narfstrom
Journal:  Neurobiol Dis       Date:  2017-08-30       Impact factor: 5.996

6.  Pupillary light reflex deficits in a canine model of late infantile neuronal ceroid lipofuscinosis.

Authors:  Rebecca E H Whiting; Kristina Narfström; Gang Yao; Jacqueline W Pearce; Joan R Coates; Leilani J Castaner; Martin L Katz
Journal:  Exp Eye Res       Date:  2013-10-14       Impact factor: 3.467

7.  Advances in the Treatment of Neuronal Ceroid Lipofuscinosis.

Authors:  Jonathan B Rosenberg; Alvin Chen; Stephen M Kaminsky; Ronald G Crystal; Dolan Sondhi
Journal:  Expert Opin Orphan Drugs       Date:  2019-11-27       Impact factor: 0.694

8.  Identification of a novel idiopathic epilepsy locus in Belgian Shepherd dogs.

Authors:  Eija H Seppälä; Lotta L E Koskinen; Christina H Gulløv; Päivi Jokinen; Peter Karlskov-Mortensen; Luciana Bergamasco; Izabella Baranowska Körberg; Sigitas Cizinauskas; Anita M Oberbauer; Mette Berendt; Merete Fredholm; Hannes Lohi
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

9.  A missense mutation in canine CLN6 in an Australian shepherd with neuronal ceroid lipofuscinosis.

Authors:  Martin L Katz; Fabiana H Farias; Douglas N Sanders; Rong Zeng; Shahnawaz Khan; Gary S Johnson; Dennis P O'Brien
Journal:  J Biomed Biotechnol       Date:  2010-12-22

10.  A one base pair deletion in the canine ATP13A2 gene causes exon skipping and late-onset neuronal ceroid lipofuscinosis in the Tibetan terrier.

Authors:  Anne Wöhlke; Ute Philipp; Patricia Bock; Andreas Beineke; Peter Lichtner; Thomas Meitinger; Ottmar Distl
Journal:  PLoS Genet       Date:  2011-10-13       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.